Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

Published:2014-01-26 Issue:6 Volume:15 Page:373-380
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Bloch M¹,Tong WWY²^ORCID,Hoy J³,Baker D⁴,Lee FJ²,Richardson R²,Carr A²,

Affiliation:

1. Holdsworth House Medical Practice; Sydney NSW Australia

2. St Vincent's Hospital and University of New South Wales; Sydney NSW Australia

3. The Alfred Hospital and Monash University; Melbourne Vic. Australia

4. East Sydney Doctors; Sydney NSW Australia

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference19 articles.

1. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system;Triant;J Clin Endocrinol Metab,2008

2. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review;Brown;AIDS,2006

3. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial;Gallant;JAMA,2004

4. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study;Stellbrink;Clin Infect Dis,2010

5. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: aids clinical trials group A5224s, a substudy of ACTG A5202;McComsey;J Infect Dis,2011

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical considerations when switching antiretroviral therapy;Expert Review of Clinical Pharmacology;2024-06-17

2. Effects of Tenofovir Disoproxil Fumarate on Bone Quality beyond Bone Density—A Scoping Review of the Literature;Pharmaceuticals;2024-01-23

3. HIV and fracture: Risk, assessment and intervention;HIV Medicine;2023-12-12

4. Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review;Frontiers in Endocrinology;2023-01-11

5. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3